US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEAYA Biosciences

18.63

+0.45002.48%

Post-market: 18.38-0.2500-1.34%17:01 EDT

Volume:1.77M

Turnover:32.78M

Market Cap:1.63B

PE:-5.54

High:18.80

Open:18.29

Low:17.99

Close:18.18

Loading ...

Overview Company News Filings

IDEAYA Biosciences’ Trial Expansion and Regulatory Uncertainties Lead to Hold Rating

Mizuho Securities Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)

Ideaya trial design consisent with guidance, says Oppenheimer

Ideaya Biosciences Completes Phase 3 Trial Design Meetings With FDA; Shares Up Pre-Bell

MT Newswires Live

BRIEF-Ideaya Biosciences Announces Successful FDA Type D Meeting for Darovasertib

IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma

THOMSON REUTERS

IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma

Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy

MT Newswires Live

IDEAYA Biosciences Inc - to Initiate Trial of Ide397 and Ide892 in H2 2025

THOMSON REUTERS

IDEAYA Biosciences Announces Board Restructuring Plans

IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events

IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

BUZZ-Ideaya falls as analysts cautious despite eye cancer drug receiving FDA's 'breakthrough' tag

IDEAYA's Eye Cancer Therapy Receives Breakthrough Therapy Designation From FDA

MT Newswires Live

BRIEF-IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation For Darovasertib Monotherapy In Neoadjuvant Uveal Melanoma

IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma

THOMSON REUTERS

IDEAYA Biosciences Inc: Targeting to Initiate a Ph3 Registrational Study in Neoadjuvant Um in H1 2025

THOMSON REUTERS

BRIEF-IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IDYA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":18.63,"timestamp":1745352000000,"preClose":18.18,"halted":0,"volume":1771676,"hourTrading":{"tag":"盘后","latestPrice":18.38,"preClose":18.63,"latestTime":"17:01 EDT","volume":192674,"amount":3589513.5372160003,"timestamp":1745355715224},"delay":0,"floatShares":86629330,"shares":87537391,"eps":-3.360473,"marketStatus":"Post-Mkt","change":0.45,"latestTime":"04-22 17:07:09 EDT","open":18.29,"high":18.8,"low":17.99,"amount":32777313.496887997,"amplitude":0.044554,"askPrice":18.63,"askSize":5,"bidPrice":18.15,"bidSize":49,"shortable":3,"etf":0,"ttmEps":-3.360473,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":4,"adr":0,"listingDate":1558584000000,"exchange":"NASDAQ","adjPreClose":18.18,"preHourTrading":{"tag":"盘前","latestPrice":18.32,"preClose":18.18,"latestTime":"08:24 EDT","volume":820,"amount":15026.03916,"timestamp":1745324665685},"postHourTrading":{"tag":"盘后","latestPrice":18.38,"preClose":18.63,"latestTime":"17:01 EDT","volume":192674,"amount":3589513.5372160003,"timestamp":1745355715224},"volumeRatio":1.28367,"impliedVol":0.4986,"impliedVolPercentile":0.288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","floatShares":86629330,"roa":"-23.05%","roe":"-32.67%","lyrEps":-3.360473,"volumeRatio":1.28367,"shares":87537391,"dividePrice":0,"high":18.8,"amplitude":0.044554,"preClose":18.18,"low":17.99,"week52Low":13.45,"pbRate":"1.54","psRate":"232.97","week52High":44.42,"institutionHeld":0,"latestPrice":18.63,"committee":0.814815,"eps":-3.360473,"divideRate":0,"volume":1771676,"delay":0,"ttmEps":-3.360473,"open":18.29,"prevYearClose":25.7,"prevWeekClose":17.08,"prevMonthClose":16.38,"prevQuarterClose":16.38,"fiveDayClose":17.11,"twentyDayClose":18.59,"sixtyDayClose":23.62},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDYA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527256853","title":"IDEAYA Biosciences’ Trial Expansion and Regulatory Uncertainties Lead to Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2527256853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527256853?lang=en_us&edition=fundamental","pubTime":"2025-04-16 15:35","pubTimestamp":1744788939,"startTime":"0","endTime":"0","summary":"Andrew Berens, an analyst from Leerink Partners, maintained the Hold rating on IDEAYA Biosciences (IDYA – Research Report). The associated price ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ideaya-biosciences-trial-expansion-and-regulatory-uncertainties-lead-to-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ideaya-biosciences-trial-expansion-and-regulatory-uncertainties-lead-to-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA"],"gpt_icon":0},{"id":"2527498492","title":"Mizuho Securities Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527498492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527498492?lang=en_us&edition=fundamental","pubTime":"2025-04-15 18:17","pubTimestamp":1744712278,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) today and set a price target of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-its-buy-rating-for-ideaya-biosciences-idya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-its-buy-rating-for-ideaya-biosciences-idya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA","MFG"],"gpt_icon":0},{"id":"2527190981","title":"Ideaya trial design consisent with guidance, says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527190981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527190981?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:50","pubTimestamp":1744645832,"startTime":"0","endTime":"0","summary":"Oppenheimer reiterates an Outperform rating on Ideaya Biosciences (IDYA) with a $40 price target after the company announced that it met with the F...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ideaya-trial-design-consisent-with-guidance-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ideaya-trial-design-consisent-with-guidance-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","BK4127","IDYA","BK4139"],"gpt_icon":0},{"id":"2527716165","title":"Ideaya Biosciences Completes Phase 3 Trial Design Meetings With FDA; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2527716165","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527716165?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:28","pubTimestamp":1744637300,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences  said Monday it has successfully completed a Type D meeting with the US Food and Drug Administration on the design of a phase 3 registrational trial to evaluate the safety and efficacy of its darovasertib precision oncology candidate to treat primary uveal melanoma.The trial is expected to start in H1 and will use eye preservation and the proportion of patients with vision loss as its primary endpoints and with no detriment to event-free-survival as a secondary endpoint for both cohorts, the oncology company said.Other secondary endpoints will include overall response rate, the proportion of patients with clinically significant macular edema and the proportion of subjects with legal blindness.Shares were almost 6% higher in recent premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2527074135","title":"BRIEF-Ideaya Biosciences Announces Successful FDA Type D Meeting for Darovasertib","url":"https://stock-news.laohu8.com/highlight/detail?id=2527074135","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527074135?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:08","pubTimestamp":1744625297,"startTime":"0","endTime":"0","summary":"BRIEF-Ideaya Biosciences Announces Successful FDA Type D Meeting for DarovasertibApril 14 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIOSCIENCES ANNOUNCES SUCCESSFUL FDA TYPE D MEETING ON PHASE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ077:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2527336821","title":"IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2527336821","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527336821?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:00","pubTimestamp":1744624817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ077:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2527158632","title":"IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2527158632","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527158632?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:00","pubTimestamp":1744624800,"startTime":"0","endTime":"0","summary":"Targeting to initiate Phase 3 randomized registrational trial for darovasertib in the neoadjuvant setting in primary UM in H1 2025. Clinical endpoints supportive of full approval based on FDA Type D Meeting: Eye preservation rate as the primary endpoint for enucleation patients. Proportion of patients with best corrected visual acuity 15-letter loss from time of randomization and time of completion of plaque brachytherapy  as the primary endpoint for PB patients. No detriment to Event-Free-Survival  is required for both cohorts as a secondary endpoint. We project registrational trial enrollment for the enucleation cohort will be 120 patients and 400 patients for the plaque brachytherapy cohort with a 2:1 randomization. Potential to submit the enucleation cohort data for regulatory review earlier than the PB cohort pending the EFS data maturity in both cohorts. FDA Guidance from the Type D Meeting on the Phase 3 Neoadjuvant Darovasertib Registrational Trial Design for Potential Regulato","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ideaya-biosciences-announces-successful-fda-100000977.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ideaya-biosciences-announces-successful-fda-100000977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PB","BK4139","IDYA","BK4211"],"gpt_icon":0},{"id":"2526955292","title":"Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy","url":"https://stock-news.laohu8.com/highlight/detail?id=2526955292","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526955292?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:18","pubTimestamp":1744283886,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences (IDYA) said Thursday it launched a phase 1/2 expansion in a clinical trial of its experimental IDE397 treatment in combination with Gilead Sciences' (GILD) Trodelvy in methylthioade","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","BK4583","BK4532","LU2089984988.USD","IE00BKVL7J92.USD","LU1430594728.SGD","BK4585","LU1839511570.USD","LU2468319806.SGD","BK4139","LU1066051498.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE0002270589.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","BK4568","LU0320765992.SGD","IE00B19Z3581.USD","BK4578","IDYA","LU0889565916.HKD","LU1066053197.SGD","LU1571399168.USD","LU0234570918.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","GILD","IE00B3T34201.USD","LU0109394709.USD","LU2087621335.USD","BK4588","BK4550"],"gpt_icon":0},{"id":"2526558203","title":"IDEAYA Biosciences Inc - to Initiate Trial of Ide397 and Ide892 in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526558203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526558203?lang=en_us&edition=fundamental","pubTime":"2025-04-10 18:00","pubTimestamp":1744279205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA6YM1XR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2524416044","title":"IDEAYA Biosciences Announces Board Restructuring Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2524416044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524416044?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:38","pubTimestamp":1743626303,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences ( ($IDYA) ) has shared an update. On March 28, 2025, Susan L. Kelley, M.D. notified IDEAYA Biosciences of her decision not to se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ideaya-biosciences-announces-board-restructuring-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ideaya-biosciences-announces-board-restructuring-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2524919397","title":"IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2524919397","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524919397?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:00","pubTimestamp":1743501600,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., April 1, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations events.2025 RBCCM Ophthalmology ConferenceThursday, April 3rd, 2025 at 11:30 AM ET. Fireside chat with Yujiro S. Hata, President and Chief Executive Officer andDarrin Beaupre, Chief Medical Officer, hosted by Gregory Renza, M.D., Director and Senior Biotechnology Research Analyst. Stifel 2025 Virtual Targeted Oncology ForumTuesday, April 8th, 2025 at 12:00 PM ET. Fireside chat withYujiro S. Hata, President and Chief Executive Officer, hosted by hosted by Benjamin Burnett, Ph.D., Managing Director, Equity Analyst. IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in id","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ideaya-biosciences-announces-participation-upcoming-100000728.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ideaya-biosciences-announces-participation-upcoming-100000728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2524905835","title":"IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2524905835","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524905835?lang=en_us&edition=fundamental","pubTime":"2025-04-01 05:45","pubTimestamp":1743457508,"startTime":"0","endTime":"0","summary":"Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) and keeping the price target at $58...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ideaya-biosciences-buy-rating-affirmed-amid-fda-breakthrough-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ideaya-biosciences-buy-rating-affirmed-amid-fda-breakthrough-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA"],"gpt_icon":0},{"id":"2524047975","title":"BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=2524047975","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524047975?lang=en_us&edition=fundamental","pubTime":"2025-04-01 02:29","pubTimestamp":1743445744,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, AppleMarch 31 (Reuters) - The S&P 500 and the Nasdaq declined on Monday, with technology stocks among the largest fallers, as inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3N3QE16T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKT","TSHA","BK4017","PG","EBS","IIPR","FBK","NOVA","SRPT","GSK.UK","GATE","BK4532","LITB","LU0316494557.USD","LU0820561818.USD","LU1674673428.USD","COOP","ENZ","HMST","NVAX","ELTX","SSBK","BK4539","TSYW.SI","BLUE","FLG","GT","PINS","LU1674673691.USD","SG9999014567.USD","ALSN","SG9999015358.SGD","IDYA","GLPI","SLDB","LU2552382215.SGD","LU1145028129.USD","VBTX","AIG","LU0061475181.USD","ALNY","LPLA","NEM","LYV","PL"],"gpt_icon":1},{"id":"2524460927","title":"BUZZ-Ideaya falls as analysts cautious despite eye cancer drug receiving FDA's 'breakthrough' tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2524460927","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524460927?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:40","pubTimestamp":1743439237,"startTime":"0","endTime":"0","summary":"BUZZ-Ideaya falls as analysts cautious despite eye cancer drug receiving FDA's 'breakthrough' tag        ** Shares of California-based drug developer Ideaya BiosciencesIDYA.O down 4.5% at $16.28 ** IDYA receives breakthrough therapy designation for company's experimental drug, darovasertib, to treat a type of eye cancer called neoadjuvant uveal melanoma, before surgery** Brokerage Leerink Partners says the majority of the neoadjuvant opportunity lies in the ~80% of patients scheduled for radiotherapy , which does not appear to be included in this designation ** \"The drug will likely need to show an improvement over placebo in time\" - Leerink Partners** IDYA says the drug is currently being tested in a mid-stage trial and co plans to begin a late-stage study in H1 2025** Neoadjuvant Uveal Melanoma affects 12,000 patients annually and is a high unmet medical need with no FDA-approved systemic therapies - IDYA** Stock had fallen 35.8% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3N3QE122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2523902943","title":"IDEAYA's Eye Cancer Therapy Receives Breakthrough Therapy Designation From FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2523902943","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523902943?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:51","pubTimestamp":1743421882,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences  said Monday the US Food and Drug Administration granted breakthrough therapy designation to its experimental neoadjuvant treatment, darovarsetib, to treat adult patients with primary uveal melanoma.The company said the decision was supported by interim data from an ongoing phase 2 trial, which showed 82% ocular tumor shrinkage and 61% eye preservation rates in patients.IDEAYA said it plans to initiate a phase 3 trial for the therapy in H1 2025.The breakthrough therapy designation accelerates developing and reviewing promising therapies for serious conditions, offering benefits such as intensive FDA guidance and priority review.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2523916637","title":"BRIEF-IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation For Darovasertib Monotherapy In Neoadjuvant Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2523916637","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523916637?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:03","pubTimestamp":1743415398,"startTime":"0","endTime":"0","summary":"BRIEF-IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation For Darovasertib Monotherapy In Neoadjuvant Uveal MelanomaMarch 31 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIOSCIENCE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QC07T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2523915761","title":"IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2523915761","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523915761?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:00","pubTimestamp":1743415219,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QC07T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2523168299","title":"IDEAYA Biosciences Inc: Targeting to Initiate a Ph3 Registrational Study in Neoadjuvant Um in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523168299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523168299?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:00","pubTimestamp":1743415219,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QC07T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2522579556","title":"BRIEF-IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522579556","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522579556?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:40","pubTimestamp":1743165643,"startTime":"0","endTime":"0","summary":"BRIEF-IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)March 28 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA7C3LVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2522237705","title":"IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522237705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522237705?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:00","pubTimestamp":1743156004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA7C3LVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":159,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-13","symbol":"IDYA","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":-1.49},{"market":"US","date":"2024-11-04","symbol":"IDYA","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2024-08-06","symbol":"IDYA","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-05-07","symbol":"IDYA","fiscalQuarterEnding":"2024/03","expectedEps":-0.53,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-02-20","symbol":"IDYA","fiscalQuarterEnding":"2023/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1708405200000,"reportTimeType":"pre","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.4615,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4615,"analysts":13,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IDYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IDYA","date":"2025-04-21","current":-5.447227,"percent":0.957758,"low":-34.624829,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"high":-2.252144,"avg":-16.390034,"sd":7.676325,"marketCap":1495138638},"quantilePoints":[{"date":"2020-04-24","current":-2.46525,"twenty":-4.586168,"median":-3.67862,"eighty":-2.846162,"marketCap":103478880},{"date":"2020-05-01","current":-2.554778,"twenty":-4.570838,"median":-3.625058,"eighty":-2.808687,"marketCap":107236792},{"date":"2020-05-08","current":-3.331896,"twenty":-4.550514,"median":-3.608149,"eighty":-2.808687,"marketCap":139856349},{"date":"2020-05-15","current":-3.586349,"twenty":-4.536043,"median":-3.607486,"eighty":-2.836553,"marketCap":159409644},{"date":"2020-05-22","current":-3.205701,"twenty":-4.514715,"median":-3.587162,"eighty":-2.841358,"marketCap":142490206},{"date":"2020-05-29","current":-4.489816,"twenty":-4.504702,"median":-3.587162,"eighty":-2.845201,"marketCap":199567828},{"date":"2020-06-05","current":-3.687244,"twenty":-4.504702,"median":-3.607486,"eighty":-2.849045,"marketCap":163894314},{"date":"2020-06-12","current":-3.623038,"twenty":-4.486103,"median":-3.608149,"eighty":-2.85139,"marketCap":161040433},{"date":"2020-06-19","current":-8.946377,"twenty":-4.541754,"median":-3.620131,"eighty":-2.862747,"marketCap":397657520},{"date":"2020-06-26","current":-8.77597,"twenty":-4.596272,"median":-3.653215,"eighty":-2.878833,"marketCap":390083091},{"date":"2020-07-02","current":-8.356038,"twenty":-4.618598,"median":-3.687244,"eighty":-2.911503,"marketCap":371417534},{"date":"2020-07-10","current":-8.118685,"twenty":-4.703566,"median":-3.716829,"eighty":-2.940329,"marketCap":360867436},{"date":"2020-07-17","current":-8.349952,"twenty":-4.791351,"median":-3.73451,"eighty":-2.977336,"marketCap":371147019},{"date":"2020-07-24","current":-7.242305,"twenty":-5.032659,"median":-3.745076,"eighty":-2.978765,"marketCap":321913230},{"date":"2020-07-31","current":-7.674409,"twenty":-5.142749,"median":-3.771501,"eighty":-3.002787,"marketCap":341119818},{"date":"2020-08-07","current":-7.61355,"twenty":-5.226626,"median":-3.78532,"eighty":-3.031614,"marketCap":338414665},{"date":"2020-08-14","current":-7.381617,"twenty":-5.488744,"median":-3.800563,"eighty":-3.055048,"marketCap":340912596},{"date":"2020-08-21","current":-7.048659,"twenty":-5.640772,"median":-3.816589,"eighty":-3.055637,"marketCap":325535262},{"date":"2020-08-28","current":-7.325077,"twenty":-5.676643,"median":-3.829155,"eighty":-3.074854,"marketCap":338301351},{"date":"2020-09-04","current":-7.36277,"twenty":-5.888584,"median":-3.904381,"eighty":-3.091768,"marketCap":340042181},{"date":"2020-09-11","current":-7.720857,"twenty":-6.055967,"median":-3.919034,"eighty":-3.105142,"marketCap":356580069},{"date":"2020-09-18","current":-8.273693,"twenty":-6.231062,"median":-3.963154,"eighty":-3.120016,"marketCap":382112246},{"date":"2020-09-25","current":-7.30623,"twenty":-7.042906,"median":-3.999405,"eighty":-3.123017,"marketCap":337430935},{"date":"2020-10-02","current":-8.154331,"twenty":-7.144679,"median":-4.012859,"eighty":-3.134459,"marketCap":376599617},{"date":"2020-10-09","current":-8.845376,"twenty":-7.233135,"median":-4.068307,"eighty":-3.171904,"marketCap":408514839},{"date":"2020-10-16","current":-8.418184,"twenty":-7.259802,"median":-4.104763,"eighty":-3.188239,"marketCap":388785429},{"date":"2020-10-23","current":-8.022404,"twenty":-7.318795,"median":-4.119255,"eighty":-3.202593,"marketCap":370506711},{"date":"2020-10-30","current":-7.64547,"twenty":-7.366539,"median":-4.130975,"eighty":-3.208643,"marketCap":353098408},{"date":"2020-11-06","current":-8.323951,"twenty":-7.428106,"median":-4.172274,"eighty":-3.213223,"marketCap":384433353},{"date":"2020-11-13","current":-9.670314,"twenty":-7.513606,"median":-4.199125,"eighty":-3.214735,"marketCap":388176055},{"date":"2020-11-20","current":-9.0623,"twenty":-7.619934,"median":-4.22379,"eighty":-3.237383,"marketCap":363769776},{"date":"2020-11-27","current":-9.815079,"twenty":-7.650496,"median":-4.270265,"eighty":-3.257424,"marketCap":393987074},{"date":"2020-12-04","current":-11.291683,"twenty":-7.758551,"median":-4.310957,"eighty":-3.268757,"marketCap":453259466},{"date":"2020-12-11","current":-10.30728,"twenty":-7.820117,"median":-4.318821,"eighty":-3.286417,"marketCap":413744538},{"date":"2020-12-18","current":-9.453166,"twenty":-7.919802,"median":-4.333623,"eighty":-3.310899,"marketCap":379459527},{"date":"2020-12-24","current":-9.337354,"twenty":-8.007327,"median":-4.345911,"eighty":-3.319882,"marketCap":374810712},{"date":"2020-12-31","current":-10.133562,"twenty":-8.091015,"median":-4.369631,"eighty":-3.320843,"marketCap":406771316},{"date":"2021-01-08","current":-10.126324,"twenty":-8.123554,"median":-4.38073,"eighty":-3.326128,"marketCap":406480765},{"date":"2021-01-15","current":-12.196466,"twenty":-8.150562,"median":-4.396081,"eighty":-3.333257,"marketCap":489578333},{"date":"2021-01-22","current":-13.318396,"twenty":-8.217153,"median":-4.425522,"eighty":-3.338699,"marketCap":534613729},{"date":"2021-01-29","current":-12.724859,"twenty":-8.273693,"median":-4.46871,"eighty":-3.3391,"marketCap":510788552},{"date":"2021-02-05","current":-13.933648,"twenty":-8.323951,"median":-4.508424,"eighty":-3.363122,"marketCap":559310559},{"date":"2021-02-12","current":-13.687547,"twenty":-8.361644,"median":-4.550006,"eighty":-3.367926,"marketCap":549431827},{"date":"2021-02-19","current":-12.999913,"twenty":-8.520656,"median":-4.585646,"eighty":-3.370227,"marketCap":521829488},{"date":"2021-02-26","current":-13.803359,"twenty":-8.627473,"median":-4.598275,"eighty":-3.372345,"marketCap":554080642},{"date":"2021-03-05","current":-14.33899,"twenty":-8.66338,"median":-4.631301,"eighty":-3.402009,"marketCap":575581412},{"date":"2021-03-12","current":-16.611804,"twenty":-8.7798,"median":-4.691605,"eighty":-3.410799,"marketCap":666814407},{"date":"2021-03-19","current":-16.343988,"twenty":-8.84035,"median":-4.717677,"eighty":-3.415564,"marketCap":656064022},{"date":"2021-03-26","current":-21.126111,"twenty":-8.941508,"median":-4.791351,"eighty":-3.418925,"marketCap":728745203},{"date":"2021-04-01","current":-22.285243,"twenty":-9.163635,"median":-4.928537,"eighty":-3.41949,"marketCap":768729453},{"date":"2021-04-09","current":-18.564804,"twenty":-9.293924,"median":-5.059353,"eighty":-3.428909,"marketCap":640392909},{"date":"2021-04-16","current":-17.396324,"twenty":-9.505281,"median":-5.10129,"eighty":-3.441013,"marketCap":600086205},{"date":"2021-04-23","current":-19.003246,"twenty":-9.670314,"median":-5.186016,"eighty":-3.447944,"marketCap":655516972},{"date":"2021-04-30","current":-19.594416,"twenty":-9.739801,"median":-5.226626,"eighty":-3.452635,"marketCap":675909371},{"date":"2021-05-07","current":-18.288121,"twenty":-9.832451,"median":-5.324735,"eighty":-3.459277,"marketCap":630848747},{"date":"2021-05-14","current":-20.393803,"twenty":-10.104609,"median":-5.514956,"eighty":-3.464141,"marketCap":641854163},{"date":"2021-05-21","current":-21.240496,"twenty":-10.279775,"median":-5.63553,"eighty":-3.465219,"marketCap":668502132},{"date":"2021-05-28","current":-21.062795,"twenty":-10.625764,"median":-5.656499,"eighty":-3.474365,"marketCap":662909349},{"date":"2021-06-04","current":-20.989624,"twenty":-11.26273,"median":-5.676643,"eighty":-3.484294,"marketCap":660606438},{"date":"2021-06-11","current":-21.836317,"twenty":-12.053148,"median":-5.777074,"eighty":-3.496371,"marketCap":687254407},{"date":"2021-06-18","current":-23.717857,"twenty":-12.533769,"median":-5.971041,"eighty":-3.508471,"marketCap":746472115},{"date":"2021-06-25","current":-22.484403,"twenty":-12.898577,"median":-6.065403,"eighty":-3.513532,"marketCap":707651617},{"date":"2021-07-02","current":-23.059318,"twenty":-13.144678,"median":-6.217431,"eighty":-3.51557,"marketCap":725745917},{"date":"2021-07-09","current":-21.049231,"twenty":-13.370511,"median":-6.264612,"eighty":-3.517045,"marketCap":662482433},{"date":"2021-07-16","current":-22.691914,"twenty":-13.607926,"median":-7.020167,"eighty":-3.52146,"marketCap":714182615},{"date":"2021-07-23","current":-26.682771,"twenty":-13.783092,"median":-7.08007,"eighty":-3.524544,"marketCap":839786849},{"date":"2021-07-30","current":-29.809753,"twenty":-14.04946,"median":-7.153433,"eighty":-3.531687,"marketCap":938202363},{"date":"2021-08-06","current":-28.191509,"twenty":-14.587986,"median":-7.224561,"eighty":-3.533947,"marketCap":887271377},{"date":"2021-08-13","current":-29.97068,"twenty":-15.154018,"median":-7.242857,"eighty":-3.537369,"marketCap":899989535},{"date":"2021-08-20","current":-30.290333,"twenty":-16.287529,"median":-7.254477,"eighty":-3.541434,"marketCap":909588400},{"date":"2021-08-27","current":-29.305801,"twenty":-16.592186,"median":-7.303089,"eighty":-3.542962,"marketCap":880023897},{"date":"2021-09-03","current":-31.722379,"twenty":-16.958969,"median":-7.318795,"eighty":-3.549073,"marketCap":952591312},{"date":"2021-09-10","current":-33.985523,"twenty":-17.480455,"median":-7.331359,"eighty":-3.549073,"marketCap":1020551273},{"date":"2021-09-17","current":-34.343535,"twenty":-18.002071,"median":-7.384758,"eighty":-3.550496,"marketCap":1031302001},{"date":"2021-09-24","current":-32.451188,"twenty":-18.564804,"median":-7.425593,"eighty":-3.554316,"marketCap":974476724},{"date":"2021-10-01","current":-32.655766,"twenty":-19.003246,"median":-7.482701,"eighty":-3.556676,"marketCap":980619997},{"date":"2021-10-08","current":-32.70691,"twenty":-19.603951,"median":-7.576366,"eighty":-3.556676,"marketCap":982155815},{"date":"2021-10-15","current":-29.57431,"twenty":-19.948284,"median":-7.607522,"eighty":-3.556676,"marketCap":888086943},{"date":"2021-10-22","current":-29.305801,"twenty":-20.299726,"median":-7.64547,"eighty":-3.561126,"marketCap":880023897},{"date":"2021-10-29","current":-27.413454,"twenty":-20.498333,"median":-7.666222,"eighty":-3.5648,"marketCap":823198619},{"date":"2021-11-05","current":-30.149685,"twenty":-20.989624,"median":-7.758551,"eighty":-3.569714,"marketCap":905364899},{"date":"2021-11-12","current":-29.446448,"twenty":-21.062795,"median":-7.793103,"eighty":-3.570043,"marketCap":884247397},{"date":"2021-11-19","current":-24.362497,"twenty":-21.240496,"median":-7.827655,"eighty":-3.571919,"marketCap":893738217},{"date":"2021-11-26","current":-24.981527,"twenty":-21.39159,"median":-7.890477,"eighty":-3.574612,"marketCap":916447328},{"date":"2021-12-03","current":-23.145422,"twenty":-21.857223,"median":-7.96045,"eighty":-3.584136,"marketCap":849089797},{"date":"2021-12-10","current":-22.914597,"twenty":-22.068374,"median":-8.022404,"eighty":-3.586999,"marketCap":840621993},{"date":"2021-12-17","current":-22.841153,"twenty":-22.307678,"median":-8.080851,"eighty":-3.590242,"marketCap":837927691},{"date":"2021-12-23","current":-24.519878,"twenty":-22.478131,"median":-8.112599,"eighty":-3.600896,"marketCap":899511720},{"date":"2021-12-31","current":-24.803163,"twenty":-22.661484,"median":-8.124771,"eighty":-3.607486,"marketCap":909904025},{"date":"2022-01-07","current":-18.854181,"twenty":-22.696715,"median":-8.133171,"eighty":-3.607884,"marketCap":691665623},{"date":"2022-01-14","current":-18.6968,"twenty":-22.661484,"median":-8.166895,"eighty":-3.6108,"marketCap":685892120},{"date":"2022-01-21","current":-16.01084,"twenty":-22.62885,"median":-8.217153,"eighty":-3.61443,"marketCap":587357674},{"date":"2022-01-28","current":-16.304617,"twenty":-22.589226,"median":-8.232117,"eighty":-3.61955,"marketCap":598134879},{"date":"2022-02-04","current":-16.336093,"twenty":-22.528306,"median":-8.279975,"eighty":-3.626979,"marketCap":599289580},{"date":"2022-02-11","current":-15.95838,"twenty":-22.480222,"median":-8.317669,"eighty":-3.641021,"marketCap":585433173},{"date":"2022-02-18","current":-14.290147,"twenty":-22.452959,"median":-8.349952,"eighty":-3.663377,"marketCap":524234045},{"date":"2022-02-25","current":-14.300639,"twenty":-22.416661,"median":-8.361644,"eighty":-3.680345,"marketCap":524618945},{"date":"2022-03-04","current":-12.663882,"twenty":-22.374982,"median":-8.467308,"eighty":-3.689682,"marketCap":464574517},{"date":"2022-03-11","current":-13.4298,"twenty":-22.27281,"median":-8.578381,"eighty":-3.700816,"marketCap":492672230},{"date":"2022-03-18","current":-9.803903,"twenty":-22.210534,"median":-8.63295,"eighty":-3.710538,"marketCap":487861813},{"date":"2022-03-25","current":-8.880178,"twenty":-22.137363,"median":-8.648165,"eighty":-3.728362,"marketCap":441895419},{"date":"2022-04-01","current":-8.849128,"twenty":-22.038758,"median":-8.676953,"eighty":-3.732947,"marketCap":440350330},{"date":"2022-04-08","current":-8.771505,"twenty":-22.005987,"median":-8.686118,"eighty":-3.735526,"marketCap":436487608},{"date":"2022-04-14","current":-8.39891,"twenty":-21.980806,"median":-8.678356,"eighty":-3.739591,"marketCap":417946542},{"date":"2022-04-22","current":-8.297999,"twenty":-21.967416,"median":-8.654251,"eighty":-3.742674,"marketCap":412925003},{"date":"2022-04-29","current":-7.445176,"twenty":-21.940847,"median":-8.644345,"eighty":-3.747479,"marketCap":370486844},{"date":"2022-05-06","current":-7.080292,"twenty":-21.836317,"median":-8.631683,"eighty":-3.752283,"marketCap":352329512},{"date":"2022-05-13","current":-7.388684,"twenty":-21.606351,"median":-8.578381,"eighty":-3.771501,"marketCap":404559983},{"date":"2022-05-20","current":-7.762705,"twenty":-21.554086,"median":-8.467308,"eighty":-3.779737,"marketCap":425039142},{"date":"2022-05-27","current":-7.621565,"twenty":-21.406546,"median":-8.392554,"eighty":-3.780239,"marketCap":417311157},{"date":"2022-06-03","current":-8.397835,"twenty":-21.39159,"median":-8.36786,"eighty":-3.788369,"marketCap":459815071},{"date":"2022-06-10","current":-8.037928,"twenty":-21.387041,"median":-8.380207,"eighty":-3.794466,"marketCap":440108711},{"date":"2022-06-17","current":-8.729514,"twenty":-21.336664,"median":-8.392554,"eighty":-3.799547,"marketCap":477975835},{"date":"2022-06-24","current":-9.795122,"twenty":-21.273946,"median":-8.39891,"eighty":-3.80666,"marketCap":536322117},{"date":"2022-07-01","current":-10.10563,"twenty":-21.225131,"median":-8.471248,"eighty":-3.810725,"marketCap":553323683},{"date":"2022-07-08","current":-10.888958,"twenty":-21.198073,"median":-8.557964,"eighty":-3.815416,"marketCap":596213996},{"date":"2022-07-15","current":-10.938357,"twenty":-21.154154,"median":-8.623821,"eighty":-3.823859,"marketCap":598918791},{"date":"2022-07-22","current":-10.50788,"twenty":-21.113328,"median":-8.640812,"eighty":-3.827243,"marketCap":575348438},{"date":"2022-07-29","current":-10.529051,"twenty":-21.08161,"median":-8.648165,"eighty":-3.852269,"marketCap":576507636},{"date":"2022-08-05","current":-11.107725,"twenty":-21.062795,"median":-8.674304,"eighty":-3.89073,"marketCap":608192372},{"date":"2022-08-12","current":-11.044212,"twenty":-21.057369,"median":-8.686118,"eighty":-3.902788,"marketCap":604714779},{"date":"2022-08-19","current":-6.087169,"twenty":-21.027635,"median":-8.674304,"eighty":-3.912344,"marketCap":400919180},{"date":"2022-08-26","current":-5.735068,"twenty":-20.992994,"median":-8.648165,"eighty":-3.917696,"marketCap":377728757},{"date":"2022-09-02","current":-5.597808,"twenty":-20.953825,"median":-8.640812,"eighty":-3.930533,"marketCap":368688422},{"date":"2022-09-09","current":-5.520226,"twenty":-20.872033,"median":-8.630797,"eighty":-3.94283,"marketCap":363578668},{"date":"2022-09-16","current":-7.849101,"twenty":-20.73156,"median":-8.578381,"eighty":-3.96417,"marketCap":516965327},{"date":"2022-09-23","current":-8.510226,"twenty":-20.611725,"median":-8.513329,"eighty":-3.972574,"marketCap":560509001},{"date":"2022-09-30","current":-10.493601,"twenty":-20.565232,"median":-8.578381,"eighty":-3.993719,"marketCap":691140025},{"date":"2022-10-07","current":-10.198204,"twenty":-20.477427,"median":-8.630797,"eighty":-4.008882,"marketCap":671684341},{"date":"2022-10-14","current":-10.950762,"twenty":-20.387531,"median":-8.642079,"eighty":-4.009677,"marketCap":721250013},{"date":"2022-10-21","current":-11.562654,"twenty":-20.357199,"median":-8.654251,"eighty":-4.014693,"marketCap":761551073},{"date":"2022-10-28","current":-11.956516,"twenty":-20.32892,"median":-8.675551,"eighty":-4.030286,"marketCap":787491986},{"date":"2022-11-04","current":-12.005748,"twenty":-20.283001,"median":-8.686118,"eighty":-4.065307,"marketCap":790734600},{"date":"2022-11-11","current":-15.768029,"twenty":-20.180562,"median":-8.713449,"eighty":-4.079563,"marketCap":830439027},{"date":"2022-11-18","current":-16.115182,"twenty":-20.035419,"median":-8.773737,"eighty":-4.104617,"marketCap":848722157},{"date":"2022-11-25","current":-16.060368,"twenty":-20.023491,"median":-8.779267,"eighty":-4.104763,"marketCap":845835347},{"date":"2022-12-02","current":-16.425792,"twenty":-19.948284,"median":-8.800314,"eighty":-4.104763,"marketCap":865080747},{"date":"2022-12-09","current":-15.384334,"twenty":-19.937676,"median":-8.842235,"eighty":-4.115583,"marketCap":810231356},{"date":"2022-12-16","current":-15.39347,"twenty":-19.766046,"median":-8.880178,"eighty":-4.122926,"marketCap":810712491},{"date":"2022-12-23","current":-15.548775,"twenty":-19.620281,"median":-8.920409,"eighty":-4.130826,"marketCap":818891787},{"date":"2022-12-30","current":-16.599368,"twenty":-19.607217,"median":-8.936255,"eighty":-4.130945,"marketCap":874222313},{"date":"2023-01-06","current":-15.777165,"twenty":-19.59823,"median":-8.94733,"eighty":-4.146129,"marketCap":830920162},{"date":"2023-01-13","current":-17.101825,"twenty":-19.554345,"median":-9.043188,"eighty":-4.162328,"marketCap":900684738},{"date":"2023-01-20","current":-16.106046,"twenty":-19.478065,"median":-9.066475,"eighty":-4.171098,"marketCap":848241022},{"date":"2023-01-27","current":-15.420877,"twenty":-19.243528,"median":-9.155743,"eighty":-4.18158,"marketCap":812155896},{"date":"2023-02-03","current":-16.042097,"twenty":-18.988351,"median":-9.163635,"eighty":-4.19168,"marketCap":844873077},{"date":"2023-02-10","current":-16.416656,"twenty":-18.921278,"median":-9.21308,"eighty":-4.201222,"marketCap":864599612},{"date":"2023-02-17","current":-16.16086,"twenty":-18.818457,"median":-9.237619,"eighty":-4.208561,"marketCap":851127832},{"date":"2023-02-24","current":-15.567046,"twenty":-18.755454,"median":-9.279961,"eighty":-4.218427,"marketCap":819854057},{"date":"2023-03-03","current":-15.7863,"twenty":-18.713587,"median":-9.288903,"eighty":-4.239786,"marketCap":831401297},{"date":"2023-03-10","current":-12.695923,"twenty":-18.685623,"median":-9.337354,"eighty":-4.268913,"marketCap":744679346},{"date":"2023-03-17","current":-12.365944,"twenty":-18.625694,"median":-9.47488,"eighty":-4.277714,"marketCap":725324457},{"date":"2023-03-24","current":-11.450254,"twenty":-18.520909,"median":-9.51831,"eighty":-4.30099,"marketCap":671614641},{"date":"2023-03-31","current":-11.326512,"twenty":-18.333889,"median":-9.637448,"eighty":-4.31253,"marketCap":664356558},{"date":"2023-04-06","current":-11.343011,"twenty":-18.288121,"median":-9.673933,"eighty":-4.318821,"marketCap":665324302},{"date":"2023-04-14","current":-11.433755,"twenty":-18.224659,"median":-9.699267,"eighty":-4.318821,"marketCap":670646896},{"date":"2023-04-21","current":-12.012005,"twenty":-18.140723,"median":-9.745723,"eighty":-4.318821,"marketCap":704564136},{"date":"2023-04-28","current":-17.665967,"twenty":-18.140723,"median":-9.757173,"eighty":-4.324014,"marketCap":1036197283},{"date":"2023-05-05","current":-18.5444,"twenty":-18.345331,"median":-9.795122,"eighty":-4.333623,"marketCap":1087721785},{"date":"2023-05-12","current":-17.975574,"twenty":-18.548481,"median":-9.809491,"eighty":-4.342105,"marketCap":1227408161},{"date":"2023-05-19","current":-17.7789,"twenty":-18.385145,"median":-9.923908,"eighty":-4.345574,"marketCap":1213978850},{"date":"2023-05-26","current":-18.14807,"twenty":-18.548481,"median":-10.050322,"eighty":-4.359142,"marketCap":1239186528},{"date":"2023-06-02","current":-20.069433,"twenty":-18.624,"median":-10.097881,"eighty":-4.366759,"marketCap":1370381033},{"date":"2023-06-09","current":-21.42026,"twenty":-18.679679,"median":-10.133562,"eighty":-4.369631,"marketCap":1462618218},{"date":"2023-06-16","current":-20.925237,"twenty":-18.866911,"median":-10.16981,"eighty":-4.375728,"marketCap":1428817014},{"date":"2023-06-23","current":-21.134993,"twenty":-18.937913,"median":-10.21543,"eighty":-4.380543,"marketCap":1443139558},{"date":"2023-06-30","current":-19.937075,"twenty":-19.13128,"median":-10.25893,"eighty":-4.382308,"marketCap":1361343322},{"date":"2023-07-07","current":-19.327719,"twenty":-19.403716,"median":-10.300042,"eighty":-4.384874,"marketCap":1319735326},{"date":"2023-07-14","current":-19.516534,"twenty":-19.527631,"median":-10.366739,"eighty":-4.396081,"marketCap":1332627944},{"date":"2023-07-21","current":-18.778441,"twenty":-19.516534,"median":-10.433806,"eighty":-4.40569,"marketCap":1282229526},{"date":"2023-07-28","current":-18.083261,"twenty":-19.456456,"median":-10.472595,"eighty":-4.425522,"marketCap":1234761248},{"date":"2023-08-04","current":-18.684034,"twenty":-19.430709,"median":-10.508916,"eighty":-4.445846,"marketCap":1275783217},{"date":"2023-08-11","current":-19.793943,"twenty":-19.456456,"median":-10.529051,"eighty":-4.466169,"marketCap":1467760467},{"date":"2023-08-18","current":-19.297154,"twenty":-19.516534,"median":-10.56417,"eighty":-4.47125,"marketCap":1430922557},{"date":"2023-08-25","current":-21.788862,"twenty":-19.594416,"median":-10.725698,"eighty":-4.489816,"marketCap":1615687698},{"date":"2023-09-01","current":-22.790203,"twenty":-19.620281,"median":-10.783103,"eighty":-4.508424,"marketCap":1689939110},{"date":"2023-09-08","current":-21.773337,"twenty":-19.662379,"median":-10.81952,"eighty":-4.516812,"marketCap":1614536513},{"date":"2023-09-15","current":-22.891113,"twenty":-19.937195,"median":-10.874844,"eighty":-4.541754,"marketCap":1697421810},{"date":"2023-09-22","current":-21.88201,"twenty":-20.044607,"median":-10.927771,"eighty":-4.55153,"marketCap":1622594806},{"date":"2023-09-29","current":-20.640037,"twenty":-20.232827,"median":-10.973642,"eighty":-4.576935,"marketCap":1530500032},{"date":"2023-10-06","current":-20.546889,"twenty":-20.307025,"median":-10.998264,"eighty":-4.587214,"marketCap":1523592923},{"date":"2023-10-13","current":-21.191163,"twenty":-20.399581,"median":-11.044212,"eighty":-4.596272,"marketCap":1571367088},{"date":"2023-10-20","current":-20.127723,"twenty":-20.430908,"median":-11.063294,"eighty":-4.598275,"marketCap":1492510937},{"date":"2023-10-27","current":-22.829497,"twenty":-20.455558,"median":-11.08551,"eighty":-4.599291,"marketCap":1692852872},{"date":"2023-11-03","current":-25.350703,"twenty":-20.512907,"median":-11.133626,"eighty":-4.606404,"marketCap":1879805335},{"date":"2023-11-10","current":-18.349717,"twenty":-20.534125,"median":-11.159417,"eighty":-4.623679,"marketCap":1893819287},{"date":"2023-11-17","current":-18.699474,"twenty":-20.512907,"median":-11.219301,"eighty":-4.647268,"marketCap":1929916591},{"date":"2023-11-24","current":-19.986078,"twenty":-20.508077,"median":-11.235768,"eighty":-4.660326,"marketCap":2062703104},{"date":"2023-12-01","current":-19.642567,"twenty":-20.498333,"median":-11.326512,"eighty":-4.691605,"marketCap":2027250394},{"date":"2023-12-08","current":-19.523899,"twenty":-20.469266,"median":-11.343011,"eighty":-4.703566,"marketCap":2015003094},{"date":"2023-12-15","current":-21.372612,"twenty":-20.485729,"median":-11.403123,"eighty":-4.710056,"marketCap":2205803131},{"date":"2023-12-22","current":-21.178997,"twenty":-20.539127,"median":-11.433755,"eighty":-4.725299,"marketCap":2185820695},{"date":"2023-12-29","current":-22.378161,"twenty":-20.560916,"median":-11.460738,"eighty":-4.752445,"marketCap":2309582881},{"date":"2024-01-05","current":-21.616192,"twenty":-20.635863,"median":-11.478255,"eighty":-4.774704,"marketCap":2230942325},{"date":"2024-01-12","current":-24.694637,"twenty":-20.763319,"median":-11.573996,"eighty":-4.807425,"marketCap":2548659433},{"date":"2024-01-19","current":-28.378521,"twenty":-20.874895,"median":-11.672989,"eighty":-4.871722,"marketCap":2928862002},{"date":"2024-01-26","current":-30.347082,"twenty":-20.925237,"median":-11.754932,"eighty":-4.928537,"marketCap":3132031295},{"date":"2024-02-02","current":-31.796601,"twenty":-20.995241,"median":-11.84903,"eighty":-5.022175,"marketCap":3281631848},{"date":"2024-02-09","current":-31.989395,"twenty":-21.094154,"median":-11.907283,"eighty":-5.032659,"marketCap":3301529459},{"date":"2024-02-16","current":-33.160435,"twenty":-21.134993,"median":-12.008876,"eighty":-5.086047,"marketCap":3422389019},{"date":"2024-02-23","current":-29.405371,"twenty":-21.18143,"median":-12.106086,"eighty":-5.094177,"marketCap":3321660162},{"date":"2024-03-01","current":-29.504379,"twenty":-21.252364,"median":-12.196466,"eighty":-5.100274,"marketCap":3332844203},{"date":"2024-03-08","current":-29.854208,"twenty":-21.362618,"median":-12.275201,"eighty":-5.134457,"marketCap":3372361147},{"date":"2024-03-15","current":-29.570385,"twenty":-21.39159,"median":-12.312278,"eighty":-5.167912,"marketCap":3340300230},{"date":"2024-03-22","current":-30.118229,"twenty":-21.456111,"median":-12.35282,"eighty":-5.193104,"marketCap":3402185256},{"date":"2024-03-28","current":-28.586905,"twenty":-21.586005,"median":-12.411316,"eighty":-5.211962,"marketCap":3229205423},{"date":"2024-04-05","current":-27.326204,"twenty":-21.698819,"median":-12.663882,"eighty":-5.224529,"marketCap":3086795302},{"date":"2024-04-12","current":-28.685913,"twenty":-21.801282,"median":-12.695915,"eighty":-5.23565,"marketCap":3240389464},{"date":"2024-04-19","current":-24.831203,"twenty":-21.90599,"median":-12.746573,"eighty":-5.260951,"marketCap":2804957470},{"date":"2024-04-26","current":-25.561122,"twenty":-21.970513,"median":-12.778856,"eighty":-5.33492,"marketCap":2887409933},{"date":"2024-05-03","current":-27.460667,"twenty":-22.002271,"median":-12.852662,"eighty":-5.443511,"marketCap":3101984415},{"date":"2024-05-10","current":-23.864016,"twenty":-22.106629,"median":-13.01501,"eighty":-5.504053,"marketCap":3075904561},{"date":"2024-05-17","current":-24.386628,"twenty":-22.316456,"median":-13.122963,"eighty":-5.514677,"marketCap":3143265660},{"date":"2024-05-24","current":-22.578036,"twenty":-22.408348,"median":-13.19089,"eighty":-5.517064,"marketCap":2910150846},{"date":"2024-05-31","current":-21.016071,"twenty":-22.408348,"median":-13.405255,"eighty":-5.517064,"marketCap":2708824416},{"date":"2024-06-07","current":-23.270938,"twenty":-22.480222,"median":-13.492753,"eighty":-5.517064,"marketCap":2999461067},{"date":"2024-06-14","current":-22.859895,"twenty":-22.573944,"median":-13.658594,"eighty":-5.526194,"marketCap":2946480428},{"date":"2024-06-21","current":-21.297929,"twenty":-22.578036,"median":-13.849482,"eighty":-5.550065,"marketCap":2745153997},{"date":"2024-06-28","current":-20.18224,"twenty":-22.604654,"median":-14.065248,"eighty":-5.737455,"marketCap":2601349404},{"date":"2024-07-05","current":-19.548058,"twenty":-22.604654,"median":-14.207014,"eighty":-5.875249,"marketCap":2519607846},{"date":"2024-07-12","current":-25.833502,"twenty":-22.663386,"median":-14.56294,"eighty":-6.158782,"marketCap":3329757590},{"date":"2024-07-15","current":-26.081274,"twenty":-22.683944,"median":-14.611833,"eighty":-6.204137,"marketCap":3361693680},{"date":"2024-08-02","current":-27.685273,"twenty":-22.729538,"median":-15.101131,"eighty":-7.080248,"marketCap":3568437841},{"date":"2024-08-09","current":-20.650678,"twenty":-22.791755,"median":-15.174216,"eighty":-7.173892,"marketCap":3174814544},{"date":"2024-08-16","current":-20.941919,"twenty":-22.791755,"median":-15.356928,"eighty":-7.243187,"marketCap":3219589736},{"date":"2024-08-23","current":-21.062812,"twenty":-22.791755,"median":-15.420877,"eighty":-7.280035,"marketCap":3238175665},{"date":"2024-08-30","current":-21.524403,"twenty":-22.791755,"median":-15.493961,"eighty":-7.318659,"marketCap":3309140119},{"date":"2024-09-06","current":-20.53528,"twenty":-22.791755,"median":-15.548775,"eighty":-7.330832,"marketCap":3157073430},{"date":"2024-09-13","current":-19.842894,"twenty":-22.791755,"median":-15.658402,"eighty":-7.386643,"marketCap":3050626748},{"date":"2024-09-20","current":-19.386799,"twenty":-22.791755,"median":-15.731487,"eighty":-7.41883,"marketCap":2980507108},{"date":"2024-09-27","current":-16.76013,"twenty":-22.791755,"median":-15.7863,"eighty":-7.470507,"marketCap":2576685567},{"date":"2024-10-04","current":-16.073239,"twenty":-22.791755,"median":-15.877656,"eighty":-7.496684,"marketCap":2471083699},{"date":"2024-10-11","current":-16.595276,"twenty":-22.791755,"median":-15.923334,"eighty":-7.600254,"marketCap":2551341118},{"date":"2024-10-18","current":-16.864537,"twenty":-22.791755,"median":-15.959877,"eighty":-7.641123,"marketCap":2592737050},{"date":"2024-10-25","current":-16.045763,"twenty":-22.791755,"median":-16.042097,"eighty":-7.711567,"marketCap":2466859624},{"date":"2024-10-31","current":-16.188637,"twenty":-22.791755,"median":-16.087775,"eighty":-7.784511,"marketCap":2488824813},{"date":"2024-11-08","current":-14.552491,"twenty":-22.793308,"median":-16.087775,"eighty":-7.860776,"marketCap":2592089652},{"date":"2024-11-15","current":-14.300163,"twenty":-22.793308,"median":-16.087775,"eighty":-7.961667,"marketCap":2547145116},{"date":"2024-11-22","current":-12.907511,"twenty":-22.793308,"median":-16.087775,"eighty":-8.046396,"marketCap":2299085853},{"date":"2024-11-29","current":-13.276297,"twenty":-22.793308,"median":-16.087775,"eighty":-8.103024,"marketCap":2364774020},{"date":"2024-12-06","current":-12.795905,"twenty":-22.793308,"median":-16.087775,"eighty":-8.12743,"marketCap":2279206539},{"date":"2024-12-13","current":-12.50961,"twenty":-22.793308,"median":-16.087775,"eighty":-8.178203,"marketCap":2228211778},{"date":"2024-12-20","current":-12.029218,"twenty":-22.793308,"median":-16.087775,"eighty":-8.232893,"marketCap":2142644297},{"date":"2024-12-27","current":-12.54843,"twenty":-22.793308,"median":-16.087775,"eighty":-8.272654,"marketCap":2235126322},{"date":"2025-01-03","current":-12.208758,"twenty":-22.793308,"median":-16.087775,"eighty":-8.306032,"marketCap":2174624062},{"date":"2025-01-10","current":-12.058333,"twenty":-22.79486,"median":-16.087775,"eighty":-8.349042,"marketCap":2147830205},{"date":"2025-01-17","current":-11.024761,"twenty":-22.79486,"median":-16.087775,"eighty":-8.387198,"marketCap":1963730473},{"date":"2025-01-24","current":-11.301351,"twenty":-22.79486,"median":-16.087775,"eighty":-8.421336,"marketCap":2012996598},{"date":"2025-01-31","current":-11.587645,"twenty":-22.79486,"median":-16.087775,"eighty":-8.512709,"marketCap":2063991360},{"date":"2025-02-07","current":-11.626465,"twenty":-22.79486,"median":-16.087775,"eighty":-8.629402,"marketCap":2070905904},{"date":"2025-02-14","current":-6.537248,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1794324147},{"date":"2025-02-21","current":-6.930226,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1902187506},{"date":"2025-02-28","current":-6.455028,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1771756793},{"date":"2025-03-07","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-03-14","current":-6.046805,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1659708933},{"date":"2025-03-21","current":-5.880964,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1614189490},{"date":"2025-03-28","current":-5.558851,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1525776725},{"date":"2025-04-04","current":-4.965652,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1362957177},{"date":"2025-04-11","current":-5.029437,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1380464656},{"date":"2025-04-17","current":-5.160196,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1416354986},{"date":"2025-04-21","current":-5.447227,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1495138638}],"updateTime":1745356029029}}}